verapamil has been researched along with homoharringtonine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Baccarani, M; Candoni, A; Damiani, D; Marie, JP; Melli, C; Michelutti, A; Michieli, MG; Russo, D; Zhou, DC; Zittoun, R | 1 |
| Feng, S; Han, J; Han, M; Li, C; Li, X; Qi, J; Qian, Q; Qiu, L; Shi, H; Yan, W | 1 |
3 other study(ies) available for verapamil and homoharringtonine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
MDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colonic Neoplasms; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Gene Amplification; Harringtonines; Homoharringtonine; Humans; Leukemia-Lymphoma, Adult T-Cell; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine | 1995 |
[In vitro reversal of homoharringtonine resistance by the combination of tamoxifen and verapamil].
Topics: Animals; Drug Resistance, Neoplasm; Drug Synergism; Harringtonines; Homoharringtonine; Humans; Inhibitory Concentration 50; K562 Cells; Tamoxifen; Verapamil | 1997 |